Related Experiment Video
Updated: Aug 19, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response
Alessandro Bruno1,2, Ferdinando D'Amico1, Laurent Peyrin-Biroulet3
1Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.
Introduction:
Inflammatory bowel disease (IBD), including Crohn's disease and Ulcerative Colitis, is a chronic immune-mediated condition that requires long-term monitoring to prevent disease progression and complications. The adoption of treat-to-target strategies has highlighted the limitations of symptom-based assessment and the need for objective tools to evaluate both mucosal and transmural inflammation. In this setting, cross-sectional imaging has gained relevance, and intestinal ultrasound (IUS) has emerged as a noninvasive point-of-care modality for disease monitoring.
Aims And Methods:
As the evidence of IUS in the monitoring of IBD continues to expand, we provided a comprehensive overview of its clinical applications and supporting evidence.This narrative review summarizes the current evidence regarding the role of IUS in monitoring therapeutic response in IBD including results of retrospective and prospective studies and meta-analyses.
Results:
The IUS demonstrates high diagnostic accuracy in assessing inflammatory activity in both Crohn's disease and ulcerative colitis, with strong correlations with endoscopic and biochemical markers. In Crohn's disease, IUS enables early detection of treatment response to biologic and small-molecule therapies, assessment of transmural healing, and identification of complications such as strictures, fistulas, and abscesses. In ulcerative colitis, IUS has been shown to predict endoscopic remission, clinical response, and long-term outcomes, including the risk of colectomy. Early ultrasound assessment is also valuable in acute severe ulcerative colitis, identifying corticosteroid responses, and the need for rescue therapy or surgery. Several ultrasound-based scoring systems have been proposed; however, only a limited number have undergone robust external validation, and definitions of response and remission remain heterogeneous. Overall, IUS represents a valuable tool for personalized disease monitoring, although wider standardization using validated scores is required for broader implementation.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

